ALPHAHELIX MOL.DIAGN. SK1
Research ALPHAHELIX MOL.DIAGN. SK1 (4MB) on Bullrun: market cap EUR 957.58K. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker4MB
- ExchangeF
- CountrySweden
- SectorHealthcare
- IndustryDiagnostics & Research
- CurrencyEUR
- Market capEUR 957.58K
- Financial periodQ1 2026
- RevenueSEK 9.00M
- Net income-SEK 169.00K
- Free cash flow-SEK 1.21M
- Gross margin53.9%
Valuation Snapshot
latest market cap is EUR 957.58K.
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-27 | EUR 957.58K | n/a | n/a | 0 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0 EUR.
About ALPHAHELIX MOL.DIAGN. SK1
Level Bio AB (publ) manufactures and distributes cutting-edge solutions in the Nordic region and internationally. It develops and manufactures diagnostic kits for the clinical market, as well as act as a distributor and full service partner to molecular biology labs in the Nordics. The company was formerly known as AlphaHelix Molecular Diagnostics AB (publ) and changed its name to Level Bio AB (publ) in May 2024. Level Bio AB (publ) was incorporated in 1998 and is headquartered in Stockholm, Sweden.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is ALPHAHELIX MOL.DIAGN. SK1's market cap?
ALPHAHELIX MOL.DIAGN. SK1's market capitalization is EUR 957.58K.
What does ALPHAHELIX MOL.DIAGN. SK1 do?
Level Bio AB (publ) manufactures and distributes cutting-edge solutions in the Nordic region and internationally. It develops and manufactures diagnostic kits for the clinical market, as well as act as a distributor and full service partner to molecular biology labs in the Nordics. The company was formerly known as AlphaHelix Molecular Diagnostics AB (publ) and changed its name to Level Bio AB (publ) in May 2024. Level Bio AB (publ) was incorporated in 1998 and is headquartered in Stockholm, Sweden.